Shares of Liquidia (LQDA) are up $1.88, or 24%, to $9.76 in early trading, which Bloomberg attributes to an appeals court affirming a patent board decision related to the company’s patent fight with United Therapeutics (UTHR).
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on LQDA:
- Liquidia director Manning buys 279,330 common shares
- Liquidia prices 3.49M shares at $7.16 in underwritten public offering
- Liquidia Announces Pricing of Public Offering of Common Stock
- Liquidia Corporation Reports Third Quarter 2023 Financial Results and Provides Corporate Update
- Liquidia reports Q3 EPS (24c), consensus (21c)
